DGAP-News: Apricus Biosciences Announces Shareholder Update With New Focus as a Commercially-Driven Specialty Pharmaceutical Company
Apricus Biosciences, Inc.
16.02.2012 16:06
—————————————————————————
Company CEO Sets Goal to Grow Revenues in 2012 and Long-Term
SAN DIEGO, 2012-02-16 16:06 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
announced today a corporate update to address Company activities and expected
near-term events.
Dr. Bassam Damaj, Chairman, President and Chief Executive Officer of Apricus
Bio, stated,
